Article Text

Download PDFPDF
Use of Integra dermal substitute to prevent implantable device extrusion in an Olympic athlete
  1. Felicity Page,
  2. Krupali Patel,
  3. Wayne Jaffe
  1. Plastic Surgery Department, Royal Stoke University Hospital, Stoke-on-Trent, UK
  1. Correspondence to Felicity Page, felicitypage{at}


We present a challenging case of imminent metallic implant extrusion in a Paralympic athlete managed with a single-stage procedure using ‘Integra’ dermal substitute. The patient had hereditary spastic paraparesis, for which a baclofen pump delivering intrathecal medication was vital in the management of his condition. The device had been most recently implanted into the thigh after previous complications. Integra provided robust soft-tissue coverage over the implanted baclofen pump in the thigh. Different operative management strategies were considered but the use of Integra was felt to offer the least morbidity and a quick recovery. The patient was able to successfully compete in a Paralympic canoeing qualifying event the week following surgery and achieve medal success. To the authors’ knowledge, this is first case in which Integra has been used in such circumstances.

  • rehabilitation medicine
  • sports and exercise medicine
  • surgery
  • plastic and reconstructive surgery

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors All authors made significant contribution in the conception and design of the case report, drafting of the case report and the final approved version and collection of patient consent and agree to be accountable for the content of the case report. KP was also involved in the revision of the case report.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.